https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Kidneys-MS.jpg

Urology Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: Japan
  • Pages: 369
  • Published Date: 11/08/2019
  • Type: MedSuite

By 2020, the urological device market size in Japan was valued at $383 million, with over 540,000 urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.3% to reach $480 million in 2026.

Throughout this medical market research, we analyzed 31 urology companies across Japan and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the Japanese Urological Device market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Urology Procedure Volumes
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Competitive Analysis with Market Shares for Each Segment
  • Market Drivers & Limiters for Each Urological Device market
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Market Value and Industry Trends

The stone management device market, BPH treatment market and urinary incontinence management device market accounted for the vast majority of the total market in 2019. The growth in these segments is driven by the stable demand for related procedures and the increasing prevalence of prostatic and kidney diseases, fueled by the aging population of Japan. The rapidly growing aging population of the region is forcing structural changes in the market, due to the increasing prevalence of chronic and age-related diseases.

Japan Urological Devices Market Size by Segment, 2016-2026

The female urinary incontinence sling market is undergoing structural changes, due to global regulatory changes regarding transvaginal tape and mini-slings. In April 2019, the U.S. Food and Drug Administration (FDA) ordered all manufacturers of surgical mesh intended for transvaginal repair of anterior compartment prolapse (cystocele) to stop selling and distributing their products immediately. This resulted in a significant decline of the urinary incontinence sling market in Jpa

Competitive Analysis

Japan Urology Market Leaders

By 2020, the leading competitors in the urological device market included Lumenis, Boston Scientific, and BARD, collectively representing around half of the total market value. The Japanese market is highly fragmented.

Boston Scientific’s position is secured by the company’s presence in every segment of the urological market. Lumenis is focused on laser equipment, lithotripters, and other capital equipment for stone management and BPH treatment, which were the second-largest portions of the total market. BARD dominated the urinary catheter segment, which generated the overwhelming majority of the urinary incontinence management market.

A large portion of the total market was shared by competitors with less than 10% of the total market share each. The combined urological device market is primarily defined by competitors in the stone management treatment and BPH treatment market, resulting in a strong focus on disposables and capital equipment.

Segments Covered

Click on each title to view detailed market segmentation.

  • Procedure Volumes for Urological Devices – MedPro – The complete procedural analysis of the urological device market in Japan, which includes Incontinence Sling Implantation, Artificial Urinary Sphincter Implantation, Transvaginal Tape Incontinence Sling, Transobturator Incontinence Sling, Extracorporeal Shockwave Lithotripsy, Percutaneous Nephrolithotomy procedures, and multiple others for each of the analyzed market segments.
  • Urinary Incontinence Market – MedCore – This market is further segmented into market segments, such as Urinary Catheters, Urethral Bulking Agents, and Incontinence Management device markets.
  • Pelvic Organ Prolapse Repair Market – MedCore – The market is comprised of the segments for Transvaginal and Sacrocolpopexy Meshes.
  • Stone Management Market – MedCore – This market is categorized by Device Type into ESWL Equipment, ISWL Equipment, Holmium Lasers, Stone Fragment Retrieval Device, Ureteral Stent, and Ureteral Guidewire market segments.
  • Benign Prostatic Hyperplasia (BPH) Treatment Market – MedCore – This market is segmented by Device Type, including Transurethral Resection of Prostate, Laser BPH, UroLift, and Rezūm device market segments.
  • Erectile Dysfunction Market – MedCore – The market is comprised of the segments for Inflatable, Malleable, and Vacuum devices.

Detailed Market Segmentation

Japan Urology Market Segmentation - p1Japan Urology Market Segmentation - p2

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS for The JAPAN UROLOGY MARKET Report Suite

TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
JAPAN UROLOGICAL DEVICES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
PROCEDURE NUMBERS 8
MARKETS INCLUDED 9
KEY REPORT UPDATES 11
VERSION HISTORY 11
RESEARCH METHODOLOGY 12
Step 1: Project Initiation & Team Selection 12
Step 2: Prepare Data Systems and Perform Secondary Research 15
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25

DISEASE OVERVIEW

2.1 BASIC ANATOMY 26
2.1.1 Urinary System 26
2.1.1.1 Male Urinary System 27
2.1.1.2 Female Urinary System 28
2.2 DISEASE TREATMENT AND DIAGNOSTICS 29
2.2.1 Benign Prostatic Hyperplasia 29
2.2.2 Urinary Incontinence 31
2.2.3 Urinary Tract Infections 33
2.2.4 Kidney Stones 34
2.2.5 Bladder Prolapse 36
2.2.6 Overactive Bladder 37
2.2.7 Prostatitis 38
2.2.8 Erectile Dysfunction 40
2.2.9 Cancer 42
2.2.9.1 Prostate Cancer 42
2.2.9.2 Bladder Cancer 43
2.2.10 Indications for Pelvic Organ Prolapse Repair 45
PRODUCT ASSESSMENT3.1 INTRODUCTION 46
3.2 PRODUCT PORTFOLIOS 46
3.2.1 Urinary Incontinence 46
3.2.1.1 Urinary Catheters 46
3.2.1.1.1 Intermittent Catheters 46
3.2.1.1.2 Foley Catheters 47
3.2.1.1.3 Male External Catheters 48
3.2.1.2 Urethral Bulking Agents 49
3.2.1.3 Incontinence Management Devices 50
3.2.1.3.1 Female Incontinence Slings 50
3.2.1.3.2 Male Implantable Devices 51
3.2.1.4 Urine Bags 53
3.2.1.4.1 Leg Bags 53
3.2.1.4.2 Night Bags 53
3.2.2 Pelvic Organ Prolapse Repair 58
3.2.2.1 Autologous tissue as an alternative to vaginal mesh 59
3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 60
3.2.3 Stone Management 61
3.2.3.1 ESWL Equipment 61
3.2.3.2 ISWL Equipment 62
3.2.3.3 Holmium Lasers 62
3.2.3.4 Stone Fragment Retrieval Devices 63
3.2.3.5 Ureteral Stents 63
3.2.4 BPH Treatment 67
3.2.4.1 TURP 67
3.2.4.2 TUMT 68
3.2.4.3 TUNA 68
3.2.4.4 Prostatic Stents 69
3.2.4.5 Laser BPH 70
3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 71
3.2.4.5.2 Laser Vaporization of the Prostate 72
3.2.4.5.3 Laser Ablation of the Prostate 73
3.2.4.5.4 Laser Resection of the Prostate 73
3.2.4.5.5 Laser Enucleation of the Prostate 74
3.2.5 Erectile Dysfunction 76
3.2.5.1 Penile Implants 76
3.2.5.1.1 Inflatable 76
3.2.5.1.2 Malleable 77
3.2.5.2 Vacuum 77
3.3 REGULATORY ISSUES AND RECALLS 79
3.3.1 Boston Scientific 79
3.3.1.1 Stone Management 79
3.3.1.2 Nephrostomy 81
3.3.2 C. R. Bard (Becton Dickinson) 82
3.3.2.1 Urinary Incontinence 82
3.3.2.2 Stone Management 87
3.3.2.3 Urological Endoscopes 87
3.3.2.4 Prostate Cancer Treatment 87
3.3.2.5 Nephrostomy 88
3.3.3 Coloplast 90
3.3.3.1 Urinary Catheter 90
3.3.3.2 Erectile Dysfunction 90
3.3.4 Cook Medical 91
3.3.4.1 Stone Management 91
3.3.4.2 Nephrostomy 92
3.3.5 Elekta 94
3.3.5.1 Prostate Cancer Treatment 94
3.3.6 Karl Storz 95
3.3.6.1 Urological Endoscopes 95
3.3.7 Olympus 96
3.3.7.1 Urological Endoscopes 96
3.4 CLINICAL TRIALS 98
3.4.1 Boston Scientific 98
3.4.1.1 Urinary Incontinence 98
3.4.1.2 BPH Treatment 99
3.4.1.3 Urological endoscopes 100
3.4.1.4 Nephrostomy 101
3.4.1.5 Erectile Dysfunction 102
3.4.2 C. R. Bard (Becton Dickinson) 103
3.4.2.1 Urinary Incontinence 103
3.4.2.2 Prostate Cancer Treatment 105
3.4.3 Coloplast 106
3.4.3.1 Urinary Incontinence 106
3.4.4 Cook Medical 109
3.4.4.1 Nephrostomy 109
3.4.5 Elekta 111
3.4.5.1 Prostate Cancer Treatment 111
3.4.6 Ethicon 113
3.4.6.1 Urinary Incontinence 113
3.4.7 Karl Storz 115
3.4.7.1 Stone Management 115
3.4.7.2 Urological Endoscopes 117
3.4.8 LABORIE 120
3.4.8.1 Urodynamics 120
3.4.9 Medline 122
3.4.9.1 Urinary Incontinence 122
3.4.10 Olympus 123
3.4.10.1 Stone Management 123
3.4.10.2 BPH Treatment 124
3.4.10.3 Urological Endoscopes 125

JAPAN UROLOGICAL DEVICE MARKET OVERVIEW

4.1 INTRODUCTION 127
4.2 CURRENCY EXCHANGE RATE 129
4.3 MARKET OVERVIEW 130
4.4 TREND ANALYSIS BY SEGMENT 136
4.5 DRIVERS AND LIMITERS 139
4.5.1 Market Drivers 139
4.5.2 Market Limiters 140
4.6 COMPETITIVE MARKET SHARE ANALYSIS 143
4.7 MERGERS AND ACQUISITIONS 150
4.8 COMPANY PROFILES 152
4.8.1 Boston Scientific 152
4.8.2 C. R. Bard (Becton Dickinson) 154
4.8.3 Coloplast 156
4.8.4 Cook Medical 157
4.8.5 Ethicon (Johnson & Johnson) 158
4.8.6 Karl Storz 159
4.8.7 LABORIE 160
4.8.8 Olympus 161
4.9 SWOT ANALYSIS 163
4.9.1 Boston Scientific 164
4.9.2 C. R. Bard (Becton Dickinson) 166
4.9.3 Coloplast 168
4.9.4 Cook Medical 169
4.9.5 Ethicon (Johnson & Johnson) 171
4.9.6 Karl Storz 172
4.9.7 LABORIE 173
4.9.8 Olympus 174
PROCEDURE NUMBERS5.1 PROCEDURE OVERVIEW 176
5.2 URINARY INCONTINENCE PROCEDURES 181
5.2.1 Male Incontinence Management Procedures 183
5.2.2 Female Incontinence Management Procedures 185
5.3 PELVIC ORGAN PROLAPSE REPAIR 188
5.4 STONE MANAGEMENT PROCEDURES 190
5.4.1 ESWL Procedures 193
5.4.2 Transurethral Procedures 195
5.4.3 Ureteral Stent Placement Procedures 197
5.4.4 PCNL Procedures 199
5.5 BPH PROCEDURES 201
5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 204

URINARY INCONTINENCE MANAGEMENT DEVICE MARKET

6.1 INTRODUCTION 207
6.2 MARKET OVERVIEW 209
6.3 MARKET ANALYSIS AND FORECAST 214
6.3.1 Total Urinary Catheter Market 214
6.3.1.1 Intermittent Catheter Market 217
6.3.1.2 Foley Catheter Market 219
6.3.1.3 Male External Catheter Market 221
6.3.2 Urethral Bulking Agent 223
6.3.3 Total Incontinence Management Device Market 224
6.3.3.1 Total Female Incontinence Sling Market 227
6.3.3.1.1 Transvaginal Tape Female Incontinence Sling Market 232
6.3.3.1.2 Transobturator Female Incontinence Sling Market 234
6.3.3.2 Total Male Implantable Incontinence Device Market 236
6.3.3.2.1 Male Incontinence Sling Market 241
6.3.3.2.2 Male Artificial Urinary Sphincter Market 243
6.4 DRIVERS AND LIMITERS 245
6.4.1 Market Drivers 245
6.4.2 Market Limiters 245
6.5 COMPETITIVE MARKET SHARE ANALYSIS 248
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET7.1 INTRODUCTION 253
7.2 MARKET OVERVIEW 255
7.3 MARKET ANALYSIS AND FORECAST 260
7.3.1 Total Pelvic Organ Prolapse Repair Device Market 260
7.3.2 Transvaginal Mesh Market 263
7.3.3 Sacrocolpopexy Mesh Market 265
7.4 DRIVERS AND LIMITERS 267
7.4.1 Market Drivers 267
7.4.2 Market Limiters 267
7.5 COMPETITIVE MARKET SHARE ANALYSIS 269

STONE MANAGEMENT DEVICE MARKET

>8.1 INTRODUCTION 272
8.2 MARKET OVERVIEW 275
8.3 MARKET ANALYSIS AND FORECAST 281
8.3.1 ESWL Equipment Market 281
8.3.2 ISWL Equipment Market 284
8.3.3 Total Holmium Laser Market 286
8.3.3.1 Holmium Laser Equipment Market 289
8.3.3.2 Holmium Laser Fiber Market 291
8.3.4 Total Stone Fragment Retrieval Device Market 294
8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 299
8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 301
8.3.5 Ureteral Stent Market 303
8.3.6 Ureteral Guidewire Market 305
8.4 DRIVERS AND LIMITERS 307
8.4.1 Market Drivers 307
8.4.2 Market Limiters 308
8.5 COMPETITIVE MARKET SHARE ANALYSIS 310

BPH TREATMENT DEVICE MARKET

9.1 INTRODUCTION 316
9.1.1 Treatments 317
9.1.2 Comparison of TURP and Laser BPH Procedures 318
9.1.3 Emerging Technologies 318
9.2 MARKET OVERVIEW 320
9.3 MARKET ANALYSIS AND FORECAST 325
9.3.1 Total TURP Market 325
9.3.1.1 Monopolar Electrode Market 328
9.3.1.2 Bipolar Electrode Market 330
9.3.2 Total Laser BPH Market 332
9.3.2.1 Laser BPH Equipment Market 335
9.3.2.2 Laser BPH Fiber Market 337
9.3.3 UroLift® Market 339
9.3.4 Rezum® Market 342
9.4 DRIVERS AND LIMITERS 343
9.4.1 Market Limiters 344
9.5 COMPETITIVE MARKET SHARE ANALYSIS 347

ERECTILE DYSFUNCTION DEVICE MARKET

10.1 INTRODUCTION 351
10.1.1 Low Testosterone Pharmaceutical Delivery 352
10.2 MARKET OVERVIEW 353
10.3 MARKET ANALYSIS AND FORECAST 358
10.3.1 Inflatable Erectile Dysfunction Device Market 358
10.3.2 Malleable Erectile Dysfunction Device Market 360
10.3.3 Vacuum Erectile Dysfunction Device 362
10.4 DRIVERS AND LIMITERS 363
10.4.1 Market Drivers 363
10.4.2 Market Limiters 363
10.5 COMPETITIVE MARKET SHARE ANALYSIS 365

ABBREVIATIONS

The Urology Market Report Suite| Japan | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • BARD
  • Biolitec
  • Boston Scientific
  • Coloplast
  • Convergent
  • Cook Medical
  • Create Medical
  • Direx
  • Dornier MedTech
  • EDAP TMS
  • EMS
  • Hogy
  • Hollister
  • Intersan
  • JMS
  • Johnson & Johnson
  • Karl Storz
  • LABORIE
  • LISA Laser
  • Lumenis
  • Medline
  • Olympus
  • Richard Wolf
  • Shibuya Corporation
  • Siemens
  • Star Medtec
  • Takai
  • Teleflex
  • Terumo
  • Trimedyne
  • Urotech

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology